Novavax, Inc.
NVAX
$8.85
$0.374.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 243.65% | 220.06% | 65.60% | 48.11% | 49.84% |
| Total Depreciation and Amortization | -9.42% | 0.81% | 17.64% | 24.22% | 30.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -111.68% | -91.15% | -98.05% | -55.64% | -72.99% |
| Change in Net Operating Assets | -851.28% | -176.91% | 112.87% | 112.90% | 126.46% |
| Cash from Operations | -4,518.97% | 59.91% | 87.78% | 86.13% | 102.18% |
| Capital Expenditure | 87.02% | 81.89% | 75.72% | 70.62% | 50.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.97% | -27,497.03% | -7,519.15% | -8,687.05% | -4,265.00% |
| Cash from Investing | 152.45% | -535.58% | -246.97% | -397.44% | -391.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -372.49% | -324.67% | 98.87% | 99.11% | 99.70% |
| Issuance of Common Stock | -99.93% | -29.54% | -26.40% | 12.36% | 326.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -588.96% | 100.00% | 100.00% | 100.00% |
| Cash from Financing | -102.07% | -32.10% | 5,734.82% | 281.50% | 523.60% |
| Foreign Exchange rate Adjustments | -75.01% | -166.46% | -338.39% | 26.33% | 48,273.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -340.17% | -54.22% | 94.97% | 87.59% | 120.43% |